Compare KRMD & VTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRMD | VTN |
|---|---|---|
| Founded | 1980 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.3M | 169.7M |
| IPO Year | N/A | N/A |
| Metric | KRMD | VTN |
|---|---|---|
| Price | $5.76 | $11.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 193.5K | 41.7K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.74% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | ★ $39,070,637.00 | N/A |
| Revenue This Year | $23.36 | N/A |
| Revenue Next Year | $18.63 | N/A |
| P/E Ratio | ★ N/A | $67.06 |
| Revenue Growth | ★ 22.12 | N/A |
| 52 Week Low | $1.86 | $8.49 |
| 52 Week High | $6.11 | $10.81 |
| Indicator | KRMD | VTN |
|---|---|---|
| Relative Strength Index (RSI) | 69.43 | 67.26 |
| Support Level | $5.52 | $11.55 |
| Resistance Level | $6.11 | $11.80 |
| Average True Range (ATR) | 0.41 | 0.11 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 76.92 | 70.00 |
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Invesco Trust For Investment Grade New York Municipals is a diversified closed-end management investment company. Its objective is to provide common shareholders with a high level of current income exempt from federal as well as from New York State and New York City income taxes, consistent with preservation of capital.